B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
NCT01156909
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Chronic Fatigue Syndrome
Myalgic Encephalomyelitis
Interventions
DRUG:
Rituximab
Sponsor
Haukeland University Hospital